Lignocaine Nebulization for Attenuation of Intubation Stress Response

• Status: Not yet recruiting
• Trial end date: 2021-07-23
• Target enrollment: 0
• Participant gender: Female

Summary

To study the effect of lignocaine nebulization on attenuation of the pressor response during induction and emergence of anesthesia in patients with severe pre-eclampsia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• American Society of Anesthesiologist (ASA) II , III with severe pre-eclampsia

• Scheduled for caesarean deliveries under general anesthesia

Exclusion Criteria:

• severe obesity (BMI ≥ 40 )

• Cardiac patients

• History of diabetes

• Renal dysfunction (Elevated creatinine ≥ 2 mg\dl)

• Hepatic dysfunction (Elevated hepatic enzymes three times above normal value)

• Known fetal anomalies